Ad
related to: nurofen formulation
Search results
Results from the WOW.Com Content Network
Nurofen is a brand of range of pain-relief medication containing ibuprofen made by the English-Dutch company Reckitt Benckiser. [1] Introduced in 1983, the Nurofen brand was acquired following Reckitt Benckiser's acquisition of Boots healthcare international in 2005 for £1.93 billion, which included Nurofen, Strepsils, and Clearasil. [2]
This page was last edited on 6 November 2024, at 03:11 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
It is available under a number of brand names including Advil, Motrin, and Nurofen. [ 8 ] [ 14 ] Ibuprofen was first marketed in 1969 in the United Kingdom and in 1974 in the United States. [ 8 ] [ 13 ] It is on the World Health Organization's List of Essential Medicines . [ 15 ]
By the late 1980s, Nurofen had a 12% share of the analgesics market. Gold Greenlees Trott (GGT), who later bought BBDP then were bought by Omnicom Group in 1998 and made part of TBWA Worldwide, were commissioned to make an advert to markedly increase Nurofen's market share. Analgesics are mainly purchased by 25- to 40-year-old women.
Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form .
Ibuprofen became on sale for general pharmacy (over-the-counter) in 1983, as Nurofen. [15] Adams said in 2007 "Getting the drug approved by the two countries with the toughest regulatory authorities – the UK and the US – was a goal I wanted to achieve. For me, that was the most exciting time of all."
Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs.In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are brand names. [1]
A self-microemulsifying drug delivery system (SMEDDS) is a drug delivery system that uses a microemulsion achieved by chemical rather than mechanical means. That is, by an intrinsic property of the drug formulation, rather than by special mixing and handling.
Ad
related to: nurofen formulation